all stories

PacBio Announces Second Quarter 2026 Financial Results

Steady2 outlets reported this in 3 reports over 2 days
Wed, 5 August 2026peak 2 reports on Wed, 5 August 2026Sat, 8 August 2026

What it is about

Pacific BiosciencesGoogleResearch UseBasecamp ResearchExchange CommissionSecurities ExchangeTerms Of ServiceCalifornia, United StatesManila, Manila, PhilippinesTaiwanCytek BiosciencesCytek BorealisMark MeehanWenbin JiangStephanie OlsenCytek AuroraCytek OrionEuropean UnionLinkedinLages Associates

Who published it, and when

original reportfirst to report
manilatimes.net2 original reports
themarketsdaily.com1 original report
5 Aug, 20:09over 3 days8 Aug, 21:04

How it spread - 3 original reports

  1. Wed, 5 August 2026

    2 reports
  2. Sat, 8 August 2026

    1 report
    • themarketsdaily.com21:04

      Cytek Biosciences (NASDAQ:CTKB) reported second-quarter 2026 revenue growth of 6% year over year, supported by double-digit gains in the United States and China, while continued weakness in Europe and parts of Asia-Pacific limited overall growth. Revenue for the quarter ended June 30 was $48.1 million, compared with $45.6 million a year earlier. CEO Wenbin Jiang […]

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.